• About Us
  • Management
  • Board of Directors
  • Corporate Overview
  • Public Policy
  • Commitment to Safety
  • Vision/Mission
• Pipeline
  • Follow-On Biologics
  • INS-19
  • INS-20
  • INS-21
  • INS-22
  • Proprietary Protein Platform
  • IPLEX
  • Oncology Programs
• Science/Technology
  • People
  • Capabilities
  • Facilities
  • Technologies
• Newsroom
  • Press Releases
  • Latest Developments
  • Media Inquiries
  • News Subscription
  • Event Calendar
• Investors
  • Stock Info
  • Corporate Governance
  • SEC Filings
  • Analysts
  • Stock History
  • Email Alerts
  • Investor Relations
• Careers

Investor Relations Contact

Please Investor Relations queries to Brian Ritchie of FD at 1-212-850-5683 or via e-mail at: brian.ritchie@fd.com

• Stock info
• Corporate Governance
• Sec Filings
• Analysts
• Stock History
• Email Alerts
• Investor Relations

Press Releases

• May. 8, 2008
  /C O R R E C T I O N -- Insmed Inc./ Read More
• May. 8, 2008
  Insmed Announces First Quarter 2008 Financial Results Read More

• 

• About Us
• Pipeline
• Science/Technology
• Newsroom
• Investors
• Careers

INSMED Incorporated - 8720 Stony Point Parkway - Suite 200 - Richmond, VA 23235
Phone: 804.565.3000Copyright 2008 © All Rights Reserved.